# OptimizeRx Corp: Form DEF 14A, filed Apr 30, 2026

- Company: [OptimizeRx Corp](/companies/oprx.md) (CIK 1448431)
- Form: DEF 14A
- Filed: 2026-04-30
- Accepted by EDGAR: Apr 30, 2026, 11:15 ET
- Period: 2026-06-09
- Accession: 0001213900-26-049698
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1448431/000121390026049698/ea0287361-03.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1448431/000121390026049698/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1448431/000121390026049698/ea0287361-03.htm

Filed Apr 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-049698. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.